DEERFIELD, Ill.—Drug and medical device maker Baxter International Inc. said Thursday it completed its $380 million acquisition of the privately held pharmacy technology company Baxa Corp.
Baxa, based in Englewood, Colo., develops technology that makes the delivery of liquid oral drugs and IV fluids safer and more efficient, according to Baxter. It had $157 million in sales last year. Its products include ExactaMed syringes that provide greater accuracy for oral liquid medication doses.
Baxter, of Deerfield, Ill., said it expects a hit to 2012 earnings of 3 cents to 5 cents per share due to translation-related expenses, but the deal is expected to add to earnings afterward.